Navigation Links
Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting
Date:12/6/2010

SAN DIEGO, Dec. 6, 2010 /PRNewswire/ -- Cylene Pharmaceuticals, Inc. has been selected to present data describing the activity of their first-in-class CK2 inhibitor at the 52nd Annual Meeting of the American Society of Hematology (ASH), to be held on December 4-7 in Orlando, FL, the company announced today.  Kenna Anderes, VP Cancer Biology at Cylene, will discuss research on targeting CK2, a protein kinase that is essential for the progression of multiple myeloma but that has not been previously exploited as an anticancer target.  As the only CK2 inhibitor to have entered clinical trials, Cylene's pioneering compound, CX-4945, represents a promising new therapeutic approach to the treatment of this life-threatening blood cancer.

"The data from Kenna's lab demonstrates the importance of CK2 as a target for cancer therapeutics, validating our decision to move CX-4945 into humans.  We take pride both in being the first to take a CK2 compound into the clinic and in the recognition by ASH of the importance of this groundbreaking research," commented William G. Rice, PhD, President and CEO of Cylene Pharmaceuticals.  "The recently initiated trial in multiple myeloma is being conducted by Farnoush Abar, MD and Richard Maziarz, MD at the Oregon Health & Science University Knight Cancer Institute and by investigators who are part of the US Oncology Research nationwide network.  This trial is designed both to treat patients and simultaneously to expand our understanding of the precise role of CK2 in myeloma.  Molecular level characterization of patient samples alongside their response to CX-4945 will increase the likelihood that targeted treatment with CX-4945 will address this large unmet medical need."

The presentation schedule is:

Monday, December 6, 2010: 4:30 PM

Title: CX-4945, a Selective and Orally Biovailable Inhibitor of Protein Kinase CK2 Inhibits PI3K/Akt, JAK-STAT and NF-_
'/>"/>

SOURCE Cylene Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cylene to Present Advances with Industrys Only Clinical CK2 Inhibitor, CX-4945, at EORTC-NCI-AACR
2. Cylene to Present Advances in its Oral Inhibitor of CK2 at AACR Annual Meeting
3. Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2
4. GENFIT Selected by Windhover for the 2011 Top Biopharma Projects To Watch
5. PolyOne GLS Selected as Healthcare Industry Marketing Specialist for Santoprene™ TPV Medical Grades
6. Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
7. CSA Medical Selected to Present at AdvaMed 2010: The MedTech Conference
8. The Colorado Institute for Drug, Device and Diagnostic Development Announces Companies Selected From Its First Solicitation: Sophono, Inc., Receiving $600K; and PeptiVir, Inc., $300K
9. Neuronetics Selected by World Economic Forum as 2011 Technology Pioneer
10. Greenway Selected by Health Information Exchanges and Regional Physician Groups
11. Award-Winning Thermal Angel Selected as Winner for Outstanding Military Product of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... Pharmaceutical Care Management Association (PCMA) President and ... that could reduce prescription fraud and abuse in Medicare ... Opioid Abuse: Fighting Back on Many Fronts ," sponsored ... The briefing featured several government and industry ... fraud. The Centers for Disease Control and Prevention has ...
(Date:9/29/2014)... YORK , Sept. 29, 2014 ... GlobalData,s new report, "EU5 Sigmoidoscopes Market Outlook ... EU5 Sigmoidoscopes market. The report provides value, in ... average prices (in US dollars) within market segments ... Non-Video Sigmoidoscopes and Flexible Non-Video (Fibre) Sigmoidoscopes). ...
(Date:9/29/2014)... SAN DIEGO , 29 de septiembre ... aquí en adelante, Daiichi Sankyo) (TSE: 4568) y Ambit ... conjunta hoy que han llegado a un acuerdo de ... todas las acciones ordinarias de Ambit Biosciences a un ... medio de una oferta de licitación seguida de una ...
Breaking Medicine Technology:PCMA: How Congress Can Fight Prescription Drug Fraud and Abuse 2EU5 Sigmoidoscopes Market Outlook to 2020 2EU5 Sigmoidoscopes Market Outlook to 2020 3Daiichi Sankyo adquiere Ambit Biosciences 2Daiichi Sankyo adquiere Ambit Biosciences 3Daiichi Sankyo adquiere Ambit Biosciences 4Daiichi Sankyo adquiere Ambit Biosciences 5Daiichi Sankyo adquiere Ambit Biosciences 6Daiichi Sankyo adquiere Ambit Biosciences 7Daiichi Sankyo adquiere Ambit Biosciences 8
... 11, 2011 Isis Pharmaceuticals, Inc. (NASDAQ: ... second development candidate, ISIS-AATRx, in its collaboration with GlaxoSmithKline ... payment from GSK for the selection of ISIS-AATRx.  ISIS-AATRx ... caused by alpha-1 antitrypsin deficiency, or AATD, by inhibiting ...
... 11, 2011 Reportlinker.com announces that ... available in its catalogue: ... http://www.reportlinker.com/p0358494/North-American-External-Defibrillator-Market.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices ... state of the North American external ...
Cached Medicine Technology:Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 2Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 3Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 4North American External Defibrillator Market 2North American External Defibrillator Market 3North American External Defibrillator Market 4North American External Defibrillator Market 5North American External Defibrillator Market 6North American External Defibrillator Market 7
(Date:9/29/2014)... NAPW honors Hope H. ... Year. She is recognized with this prestigious distinction for ... professional women in the country, the National Association of ... over 600,000 members and nearly 300 Local Chapters. , ... right about turn and applied to a university that ...
(Date:9/29/2014)... 2014 NAPW honors ... Woman of the Year. Dr. Mondloch is recognized with ... medicine As the largest, most-recognized networking organization of professional ... profession, the National Association of Professional Women is a ... nearly 300 Local Chapters. , “Initially my goal was ...
(Date:9/29/2014)... 30, 2014 NAPW honors ... Warm Hearts, Inc., as a 2014 Professional Woman of ... for leadership in home health services. As the largest, ... every industry and profession, the National Association of Professional ... over 600,000 members and nearly 300 Local Chapters. , ...
(Date:9/29/2014)... 29, 2014 Every autumn, as high ... cross country running season takes off! Athletes typically train ... country running season. Zensah®, the leading compression apparel company, ... compression socks for cross country running. ... to reduce delayed onset muscle soreness (DOMS) throughout training ...
(Date:9/29/2014)... According to the senior spokesman for Fecbek, the ... and was worn by a man, Ötzi the Iceman. ... the direction of using small ornamental purses—which evolved into ... a leading online supplier of fashion accessories, has released ... are fashionable. , For most men, they do ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Hope H. Anderson, President of Hope Nutritional Services, a 2014 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Victoria J. Mondloch, M.D., Family Medicine and Women's Health, a 2014 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Rachel L. Gregus, Co-Founder of Safe Hands Warm Hearts, Inc., a 2014 Professional Woman of the Year 2Health News:Muscle Support and Style With New Compression Leg Sleeves For Cross Country Runners 2
... more stress can lead to the growth and spread of ... remarkable finding suggests that stress results in the release of ... released during stress stimulates cancer cells to produce two compounds ... the cells to move easily into the bloodstream and travel ...
... to treat seizures and migraine headaches, can increase the ... Southwestern Medical Center have found. ,A study – ... of topiramate affects kidney-stone formation – appears in the ... ,Several case reports have described an association ...
... from major depression can become symptom-free if they are ... treatments to determine which work best for them, which ... to the mix. ,The largest study on treatments ... that 67 percent of patients achieved a full remission ...
... bird flu virus has been detected in Asia, the British ... for any evidence of bird flu. ,The death ... and parks will be brought to the notice of the ... 1,200 sq Kms area will be brought under surveillance. ...
... world-wide survey which has sought to understand sexual behaviors ... pre-marital sex //in the present day are baseless and ... of this survey are published in The Lancet. ... which showed that many had just a single recent ...
... been grown from umbilical cord blood stem cells for the ... animal experiments for drug testing. ,According to the ... is just the initial phase of generating segments that can ... a mature functioning form. ,Scientists from Newcastle ...
Cached Medicine News:Health News:More Stress, More Cancer 2Health News:More Stress, More Cancer 3Health News:Drug Prescribed for Migraines and Seizures Increases Risk of Kidney Stones 2Health News:Drug Prescribed for Migraines and Seizures Increases Risk of Kidney Stones 3Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 2Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 3Health News:Artificial Liver from Cord Blood Stem cells 2
Micro-retractor arm 12"....
... designed for the retraction of nerves, vessels, tissue, ... Equalizes brain retraction pressure. Decreases shear injury to ... conjunction with the Budde Halo Retractor. Range of ... 2 mm and 4 mm wide. Quick change ...
Telescopic Diamond-Dissectors for delicate sharp tissue preparation. Total/working lengths 220/240 mm with protective sleeve....
Cone Ring Curettes, length 9" (229 mm), ring diameter (I.D.) 5/16" (8 mm)....
Medicine Products: